No. The IMAT Program solicits molecular and cellular analytical and characterization technologies across a wide-range of cross-cutting disciplines. The program encourages collaborative approaches to overcome technical barriers. The program solicits projects to develop robust technologies appropriate for basic, clinical, epidemiological, or translational research. Additionally, the program solicits applications to develop technologies to preserve sample integrity, establish quality assessment/quality control criteria, and improve handling of cancer-relevant biospecimens under diverse conditions.